期刊
DIABETES RESEARCH AND CLINICAL PRACTICE
卷 68, 期 1, 页码 S54-S59出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2005.03.007
关键词
insulin resistance; insulin sensitivity; insulin therapy; type 2 diabetes; clamp; glucose toxicity
Insulin resistance in type 2 diabetes subjects was investigated before and 6 months after insulin administration in 43 type 2 diabetes patients (28 females and 15 males). Their age was 56.1 +/- 8.6 years, diabetes duration 11.7 +/- 6.8 years, BMI 29.5 +/- 5.3 kg/m(2). All patients were on maximal dosage of oral hypoglycaemic agents and had poor metabolic control (HbA1(c) 11.2 +/- 1.6%). Insulin sensitivity was measured by euglycaemic clamp (insulin infusion rate 1 mU kg(-1) min(-1)). The glucose disposal rate (M-value) was considerably lower in patients (2.4 +/- 1.6 mg kg(-1) min(-1), 0.2-8.1) compared with healthy subjects (7.1 +/- 0.2 mg kg(-1) min(-1), p < 0.01). M-value was strongly associated with WHR (r = -0.4 1, p < 0.05). The patients with poorest insulin sensitivity had the highest level of total cholesterol (r = -0.41, p = 0.02) and LDL-cholesterol (r = -0.38, p = 0.03). After 6 months of insulin treatment BMI was 30.3 +/- 4.2 kg/m(2) (P < 0.05), mean weight increase was 2.7 +/- 0.8 kg. M-value was substantially increased to 4.5 +/- 2.3 mg kg(-1) min(-1) (p < 0.001), the degree of improvement depended on basal insulin sensitivity (r = -0.55, p < 0.01). HbA1(c), was reduced to 7.7 +/- 1.4% (p < 0.01), the correlation M-value with change of HbA1(c) (r = -0.59, p < 0.01) was shown. Total cholesterol decreased from 6.3 +/- 1.1 to 5.4 +/- 1.1 mmol/l, LDL-cholesterol from 4.1 +/- 1.1 to 3.4 +/- 1.0 mmol/l, triglycerides from 2.6 +/- 1.6 to 1.6 +/- 0.7 mmol/l (p < 0.001). In conclusion, insulin treatment of type 2 diabetes patients leads to decrease in insulin resistance due to reduction in glucose toxicity and plasma atherogenicity despite weight gain. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据